Versant Capital Management, Inc Adaptive Biotechnologies Corp Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 901 shares of ADPT stock, worth $11,406. This represents 0.0% of its overall portfolio holdings.
Number of Shares
901
Previous 332
171.39%
Holding current value
$11,406
Previous $2,000
400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ADPT
# of Institutions
256Shares Held
153MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$380 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$166 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$148 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$143 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.64MShares$84.1 Million0.01% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.81B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...